Zentalis Pharmaceuticals
ZNTL
#9381
Rank
S$0.17 B
Marketcap
S$1.75
Share price
0.00%
Change (1 day)
0.25%
Change (1 year)

EPS for Zentalis Pharmaceuticals (ZNTL)

EPS in 2026 (TTM): S-$2.35

According to Zentalis Pharmaceuticals's latest financial reports the company's current EPS (TTM) is S-$2.36. In 2021 the company made an earnings per share (EPS) of S-$4.88 a decrease over its 2020 EPS that were of S-$4.12.

EPS history for Zentalis Pharmaceuticals from 2020 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$2.35
2021S-$4.8818.48%
2020S-$4.12

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
S-$0.25-89.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
S-$1.23-48.09%๐Ÿ‡บ๐Ÿ‡ธ USA